BCN Welcomes Samantha Zuniga as Director of Business Development
In this role, Zuniga will report to
Zuniga brings extensive experience from across the channel ecosystem, having held key roles with several leading TSDs. Most recently, she served as Director of Channel Development at GTT, where she was instrumental in expanding partner engagement and driving revenue growth. Her deep understanding of the TSD landscape, combined with a strong track record of building collaborative partnerships, uniquely positions her to help BCN strengthen and expand its channel presence.
"We are thrilled to welcome Samantha to the BCN team," said
Zuniga is widely recognized for her collaborative leadership style, commitment to partner success, and ability to cultivate lasting relationships. At BCN, she will focus on aligning the company's partner strategy with its broader mission of delivering secure, scalable, and customer-focused technology solutions to multi-location businesses.
About BCN
As a Managed Network and Technology Solutions Provider since 1994, BCN delivers customized solutions that fuel growth, enhance security, and simplify complexity. Our experts guide you to the right technology, then help you secure, manage, and monitor it, ensuring seamless connectivity and performance. With hundreds of industry partnerships and an unwavering commitment to exceptional customer care, we provide the simplicity of one provider, one bill, and one portal to manage all services across multiple locations. As a privately held company, BCN serves a growing roster of customers nationally and internationally, delivering best-in-class solutions backed by personalized service and unmatched support. For more information, visit www.bcntele.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/bcn-welcomes-samantha-zuniga-as-director-of-business-development-302549084.html
SOURCE BCN Telecom
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Akeso's AK157D1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline
- Hunting PLC (“Hunting” or “the Company” or “the Group”) Results for the Six Months Ended 30 June 2026
- Implantica receives FDA approval for RefluxStop® - Opening the U.S. market
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share